Clinical Trial: Curcumin and Retinal Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Bioavailability
Study Type: INTERVENTIONAL
Official Title: Curcumin and Retinal Amyloid-beta Pilot Study
Brief Summary:
To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
Read more